Escitalopram treatment of kleptomania: An open-label trial followed by double-blind discontinuation

Journal of Clinical Psychiatry

Volumn 68, Issue 3, 2007, Pages 422-427

  Koran, Lorrin M ^a,b   Aboujaoude, Elias N ^a   Gamel, Nona N ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INSOMNIA; KLEPTOMANIA; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; SOMNOLENCE; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

EID: 33947719011     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0311     Document Type: Article

References (36)

1. Fullerton RA, Punj GN. Shoplifting as moral insanity: historical perspectives on kleptomania. J Macromarketing 2004;24:8-16
2. Durst R, Katz G, Teitelbaum A, et al. Kleptomania: diagnosis and treatment options. CNS Drugs 2001;15:185-195
3. Matthey A. Nouvelles Recherches sur les Maladies de l'Espirit. Paris, France: Paschoud; 1816
4. Esquirol E. Des Maladies Mentales. Paris, France: I.B. Baillière; 1838
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
6. Goldman, MJ. Kleptomania: The Compulsion to Steal: What Can Be Done. Far Hills, NJ: New Horizon Press; 1998
7. Bradford J, Balmaceda R. Shoplifting: is there a specific psychiatric syndrome? Can J Psychiatry 1983;28:248-253
8. Medlicott RW. Fifty thieves. N Z Med J 1968;67:183-188
9. Hollinger RC, Langton L. 2004 National Retail Security Survey: Final Report. Gainesville, Fla: University of Florida; 2005
10. Koran LM. Obsessive-Compulsive and Related Disorders in Adults: A Comprehensive Clinical Guide. New York, NY: Cambridge University Press; 1999
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
12. McElroy SL, Pope HG, Hudson JI, et al. Kleptomania: a report of 20 cases. Am J Psychiatry 1991;148:652-657
13. Grant JE, Kim SW. Clinical characteristics and associated psychopathology of 22 patients with kleptomania. Comp Psychiatry 2002;43:378-384
14. Presta S, Marazziti D, Dell'Osso L, et al. Kleptomania: clinical features and comorbidity in an Italian sample. Comp Psychiatry 2002;43:7-12
15. Aboujaoude E, Gamel N, Koran LM. Overview of kleptomania and phenomenological description of 40 patients. Prim Care Companion J Clin Psychiatry 2004;6:244-247
16. Goldman MJ. Kleptomania: making sense of the nonsensical. Am J Psychiatry 1991;148:986-996
17. Chong SA, Low BL. Treatment of kleptomania with fluvoxamine. Acta Psychiatr Scand 1996;93:314-315
18. Lepkifker E, Dannon PN, Ziv R, et al. The treatment of kleptomania with serotonin reuptake inhibitors. Clin Neuropharmacol 1999;22:40-43
19. Krause JE. Treatment of kleptomania with paroxetine [letter]. J Clin Psychiatry 1999;60:793
20. Burstein A. Fluoxetine-lithium treatment for kleptomania [letter]. J Clin Psychiatry 1992;53:28-29
21. Durst R, Katz G, Knobler HY. Buspirone augmentation of fluvoxamine in the treatment of kleptomania. J Nerv Ment Dis 1997;185:586-588
22. Dannon PN, Iancu I, Grunhaus L. Naltrexone treatment in kleptomanic patients. Hum Psychopharmacol 1999;14:583-585
23. McElroy SL, Keck PE Jr, Pope HG Jr, et al. Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol 1989;9: 358-360
24. Grant JE, Kim SW. An open-label study of naltrexone in the treatment of kleptomania. J Clin Psychiatry 2002;63:349-356
25. Grant, JE. Outcome study of kleptomania patients treated with naltrexone: a chart review. Clin Neuropharmacol 2005;28:11-14
26. Dannon PN. Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin Neuropharmacol 2003;26:1-4
27. Murdoch D, Keam SJ. Spotlight on escitalopram in the management of major depressive disorder. CNS Drugs 2006;20:167-170
28. Lecrubier Y, Sheehan D, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI): a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry 1997;12:224-231
29. Sheehan DV, Lecrubier Y, Harnett Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry 1997;12:232-241
30. Christenson GA, Faber RJ, de Zwaan M, et al. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994;55:5-11
31. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 1: development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011
32. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale, 2: validity. Arch Gen Psychiatry 1989;46: 1012-1016
33. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976: 218-222
34. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
35. Ferguson D, Glass KC, Waring D, et al. Turning a blind eye: the success of blinding reported in a random sample of randomized, placebo controlled trials. BMJ 2004;328:432-434
36. Kim SW. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry 1998;59:159-164